Treatment of respiratory failure with inhaled nitric oxide and high-frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia

Respiration

Volumn 65, Issue 6, 1998, Pages 477-480

  Hoehn, T ^a,b   Krause, M ^a   Krueger, M ^a   Hentschel, R ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Alveolar recruitment; High frequency ventilation; Inhaled nitric oxide; Lung expansion; Respiratory syncytial virus

Indexed keywords

NITRIC OXIDE; RIBAVIRIN;

ARTICLE; CASE REPORT; CLINICAL FEATURE; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THORAX RADIOGRAPHY; VIRUS PNEUMONIA;

EID: 0031783296     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029317     Document Type: Article

References (26)

1. Carmack MA, Prober CG: Respiratory syncytial virus and ribavirin: Quo vadis (review). Infect Agents Dis 1992;1:99-107.
2. McIntosh K: Infections due to respiratory syncytial virus; in Behrman RE, Vaughan VC (eds): Nelson Textbook of Pediatrics, ed 13. Philadelphia, Saunders, 1987, pp 680-682.
3. Navas L, Wang E, de Carvalho V, Robinson J: Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992;121:348-354.
4. Everard ML: Bronchiolitis. Origins and optimal management (review). Drugs 1995;49: 885-896.
5. Moler FW, Khan AS, Meliones JN, Custer JR, Palmisano J, Shope TC: Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: A recent experience. Crit Care Med 1992;20:1406-1413.
6. Randolph AG, Wang EE: Ribavirin for respirators syncytial virus lower respiratory tract infection. A systematic overview. Arch Pediatr Adolesc Med 1996;150:942-947.
7. Committee on Infectious Diseases: Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infection. Pediatrics 1996;97:137-140.
8. Ring JC, Stidham GL: Novel therapies for acute respiratory failure (review). Pediatr Clin North Am 1994;41:1325-1363.
9. Thompson MW, Bates JN, Klein JM: Treatment of respiratory failure in an infant with bronchopulmonary dysplasia infected with respiratory syncytial virus using inhaled nitric oxide and high frequency ventilation. Acta Pediatr 1995;84:100-102.
10. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC. Yoder BA, Moreland SG, Cutter GR, Abman SA: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn (PPHN). J Pediatr 1997; 131:55-62.
11. Khan JY, Kerr SJ, Tometzki A, Tyszczuk L, West J, Sosnowski A, McCrae D, Skeoch C, Davis C, Firmin RK: Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: A collaborative report. Arch Dis Child Fetal Neonatal Ed 1995;73:F91-F94.
12. Moler FW, Palmisano JM, Green TP, Custer JR: Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. J Pediatr 1993;123:46-52.
13. Paulson TE, Spear RM, Peterson BM: New concepts in the treatment of children with acute respiratory distress syndrome (review). J Pediatr 1995;127:163-175.
14. Rosenberg RB, Broner CW, Peters KJ, Anglin DL: High-frequency ventilation for acute pediatric respiratory failure. Chest 1993; 104: 1216-1221.
15. Sarnaik AP, Meert KL, Pappas MD, Simpson PM, Lieh-Lai MW, Heidemann SM: Predicting outcome in children with severe acute respiratory failure treated with high-frequency ventilation. Crit Care Med 1996;24:1396-1402.
16. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP: Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994; 124:881-888.
17. Barefield ES, Karle VA, Phillips JB 3, Carlo WA: Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996; 129:279-286.
18. Day RW, Guarin M, Lynch JM, Vernon DD, Dean JM: Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Critical Care Med 1996;24:215-221.
19. Leclerc F, Riou Y, Martinot A, Storme L, Hue V, Flurin V, Deschildre A, Sadik A: Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive Care Med 1994; 20:511-512.
20. Roberts JD Jr, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM: Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447-453.
21. Hoehn T, Krause M, Wildberg A, Pringsheim W, Leititis JU: Umkehr eines Rechts-Links-Shunts und dauerhafte Verbesserung der Oxy-genierung durch Inhalation von Stickstoffmonoxyd (NO) bei einem Frühgeborenen mit Lungenhypoplasie und Asphyxie. Z Geburtshilfe Neonatol 1997;201:105-107.
22. Änggard E: Nitric oxide: Mediator, murderer, and medicine (review). Lancet 1994;343:1199-1206.
23. Schragl E, Donner A, Kashanipour A, Ullrich R, Aloy A: Superimposed high-frequency jet ventilation (SHFJV) in the administration of NO. Technical basis and early clinical results with ARDS. Anaesthesist 1995;44:843-849.
24. Kinsella JP, Abman SH: Methaemoglobin during nitric oxide therapy with high-frequency ventilation (letter). Lancet 1993;342:615.
25. Carter JM, Gerstmann DR. Clark RH, Snyder G, Cornish JD, Null DM Jr: High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. Pediatrics 1990; 85:159-1641.
26. 2) during inhalational therapy: Effect of ventilation strategy. Pediatr Res 1996;39:A.